i*t
2 楼
赶紧下去吧
b*u
3 楼
for those who don't want to bother to root, but always having problem with
the "memory full" issue, might work on other Android phone
accidently found out that, if you use 安卓市场-->管理, you can delete those
factory installed apps, which normally you cannot remove unless root, to
free internal memory, but still being able to use those apps if you want!
the "memory full" issue, might work on other Android phone
accidently found out that, if you use 安卓市场-->管理, you can delete those
factory installed apps, which normally you cannot remove unless root, to
free internal memory, but still being able to use those apps if you want!
F*Q
4 楼
Japanese Researcher Retracts 3 Articles in AHA Journals
Akio Kawakami, a well published lipid researcher at Tokyo Medical and Dental
University, has retracted 3 papers from AHA journals, including one article
in AHA’s flagship journal Circulation. News of the retractions was first
reported on Retraction Watch.
Two of Kawakami’s co-authors are well known researchers affiliated with
Harvard University and the Brigham and Women’s Hospital, Peter Libby and
Frank Sacks. Prior to his position in Tokyo, Kawakami had been at the
Harvard School of Public Health in the Department of Nutrition, where Sacks
also works. Sacks is a co-author on all three of the retracted papers, while
Peter Libby is a co-author on one of the retracted papers. Kawakami was
also the first author of 4 other papers on which Libby and Sacks were co-
authors, including two papers published in 2006 in Circulation (here and
here).
Donna Arnett, the incoming president of the AHA, told CardioBrief that the
retractions were requested by Kawakami himself. She said he initially
contacted each of the individual journals, which then informed the AHA’s
scientific publishing committee. (Arnett is a former chair of the committee.
) “In this case it was the author himself coming forward, so it was fairly
straightforward,” said Arnett. The retraction was then coordinated with the
three journals.
Here are the 3 retractions:
From Circulation:
Notice of Retraction
The authors of the following article have requested that it be retracted
from publication inCirculation:
Kawakami A, Osaka M, Tani M, Azuma H, Sacks FM, Shimokado K, Yoshida M.
Apolipoprotein CIII links hyperlipidemia with vascular endothelial cell
dysfunction.Circulation. 2008;118:731–742.
The corresponding author, Dr Akio Kawakami, reported to the editors that
the authors of this manuscript have raised concerns related to the accuracy
of the data presented in this article. In the process of following up the
findings reported in this study, they were unable to reproduce some
experiments due to Dr Akio Kawakami’s negligence in keeping proper original
records. This information was reported to the editors by Dr Kawakami
directly. The authors apologize to the readers of Circulation for any
inconvenience caused by this retraction.
From Circulation Research:
Notice of Retraction
The authors of the following article have requested that it be retracted
from publication in Circulation Research:
Kawakami A, Osaka M, Aikawa M, Uematsu S, Akira S, Libby P, Shimokado K,
Sacks FM, Yoshida M. Toll-like receptor 2 mediates apolipoprotein CIII–
induced monocyte activation. Circ Res. 2008;103:1402–1409.
The corresponding author, Dr Akio Kawakami, admitted to the editors to
improperly handling the collection and presentation of data in this article
such that the authors can no longer verify the authenticity and accuracy of
the data presented. These errors include, but may not be limited to, the
blots in Figure 2A, Figure 4D, and Online Figure III originating from
unrelated experiments of the corresponding author, and the incorrect
reporting of “n” in Figures 5 and 6, which are less than indicated. As
such, data in those figures are not verifiable.
All co-authors involved in this study other than the corresponding
author, Dr Kawakami, had no knowledge of any scientific impropriety related
to the collection, analysis, or presentation of data in this article. Dr
Kawakami takes full responsibililty for this.
From Arteriosclerosis, Thrombosis, and Vascular Biology:
Notice of Retraction
The authors of the following article have requested that it be retracted
from publication inArteriosclerosis, Thrombosis, and Vascular Biology:
Abe Y, Kawakami A, Osaka M, Uematsu S, Akira S, Shimokado K, Sacks FM,
Yoshida M. Apolipoprotein CIII induces monocyte chemoattractant protein-1
and interleukin 6 expression via toll-like receptor 2 pathway in mouse
adipocytes. Arterioscler Thromb Vasc Biol. 2010;30:2242–2248.
The corresponding author, Dr Akio Kawakami, reported to the editors his
concerns related to the authenticity and accuracy of the data presented in
this article. Because the number of experiments was inflated in some studies
, and the corresponding author presented some data from unrelated
experiments, the results are not verifiable. All co-authors involved in this
study other than the corresponding author had no knowledge of any
scientific impropriety related to the collection, analysis, or presentation
of data in this article. Dr Kawakami apologizes for any adverse consequences
that may have resulted from the article’s publication and any
inconvenience and wasted effort that this may have caused the scientific
community and readers of the journal.
Akio Kawakami, a well published lipid researcher at Tokyo Medical and Dental
University, has retracted 3 papers from AHA journals, including one article
in AHA’s flagship journal Circulation. News of the retractions was first
reported on Retraction Watch.
Two of Kawakami’s co-authors are well known researchers affiliated with
Harvard University and the Brigham and Women’s Hospital, Peter Libby and
Frank Sacks. Prior to his position in Tokyo, Kawakami had been at the
Harvard School of Public Health in the Department of Nutrition, where Sacks
also works. Sacks is a co-author on all three of the retracted papers, while
Peter Libby is a co-author on one of the retracted papers. Kawakami was
also the first author of 4 other papers on which Libby and Sacks were co-
authors, including two papers published in 2006 in Circulation (here and
here).
Donna Arnett, the incoming president of the AHA, told CardioBrief that the
retractions were requested by Kawakami himself. She said he initially
contacted each of the individual journals, which then informed the AHA’s
scientific publishing committee. (Arnett is a former chair of the committee.
) “In this case it was the author himself coming forward, so it was fairly
straightforward,” said Arnett. The retraction was then coordinated with the
three journals.
Here are the 3 retractions:
From Circulation:
Notice of Retraction
The authors of the following article have requested that it be retracted
from publication inCirculation:
Kawakami A, Osaka M, Tani M, Azuma H, Sacks FM, Shimokado K, Yoshida M.
Apolipoprotein CIII links hyperlipidemia with vascular endothelial cell
dysfunction.Circulation. 2008;118:731–742.
The corresponding author, Dr Akio Kawakami, reported to the editors that
the authors of this manuscript have raised concerns related to the accuracy
of the data presented in this article. In the process of following up the
findings reported in this study, they were unable to reproduce some
experiments due to Dr Akio Kawakami’s negligence in keeping proper original
records. This information was reported to the editors by Dr Kawakami
directly. The authors apologize to the readers of Circulation for any
inconvenience caused by this retraction.
From Circulation Research:
Notice of Retraction
The authors of the following article have requested that it be retracted
from publication in Circulation Research:
Kawakami A, Osaka M, Aikawa M, Uematsu S, Akira S, Libby P, Shimokado K,
Sacks FM, Yoshida M. Toll-like receptor 2 mediates apolipoprotein CIII–
induced monocyte activation. Circ Res. 2008;103:1402–1409.
The corresponding author, Dr Akio Kawakami, admitted to the editors to
improperly handling the collection and presentation of data in this article
such that the authors can no longer verify the authenticity and accuracy of
the data presented. These errors include, but may not be limited to, the
blots in Figure 2A, Figure 4D, and Online Figure III originating from
unrelated experiments of the corresponding author, and the incorrect
reporting of “n” in Figures 5 and 6, which are less than indicated. As
such, data in those figures are not verifiable.
All co-authors involved in this study other than the corresponding
author, Dr Kawakami, had no knowledge of any scientific impropriety related
to the collection, analysis, or presentation of data in this article. Dr
Kawakami takes full responsibililty for this.
From Arteriosclerosis, Thrombosis, and Vascular Biology:
Notice of Retraction
The authors of the following article have requested that it be retracted
from publication inArteriosclerosis, Thrombosis, and Vascular Biology:
Abe Y, Kawakami A, Osaka M, Uematsu S, Akira S, Shimokado K, Sacks FM,
Yoshida M. Apolipoprotein CIII induces monocyte chemoattractant protein-1
and interleukin 6 expression via toll-like receptor 2 pathway in mouse
adipocytes. Arterioscler Thromb Vasc Biol. 2010;30:2242–2248.
The corresponding author, Dr Akio Kawakami, reported to the editors his
concerns related to the authenticity and accuracy of the data presented in
this article. Because the number of experiments was inflated in some studies
, and the corresponding author presented some data from unrelated
experiments, the results are not verifiable. All co-authors involved in this
study other than the corresponding author had no knowledge of any
scientific impropriety related to the collection, analysis, or presentation
of data in this article. Dr Kawakami apologizes for any adverse consequences
that may have resulted from the article’s publication and any
inconvenience and wasted effort that this may have caused the scientific
community and readers of the journal.
D*1
5 楼
去的挺多的 我在澳洲的时候 面试10个里有5-6个都是美国来的。很多人都take了。当
然那是3年多以前了 不知道现在的情况
然那是3年多以前了 不知道现在的情况
B*n
6 楼
没看到管理选项吗 你是说卸载更新？
those
【在 b***u 的大作中提到】
: for those who don't want to bother to root, but always having problem with
: the "memory full" issue, might work on other Android phone
: accidently found out that, if you use 安卓市场-->管理, you can delete those
: factory installed apps, which normally you cannot remove unless root, to
: free internal memory, but still being able to use those apps if you want!
those
【在 b***u 的大作中提到】
: for those who don't want to bother to root, but always having problem with
: the "memory full" issue, might work on other Android phone
: accidently found out that, if you use 安卓市场-->管理, you can delete those
: factory installed apps, which normally you cannot remove unless root, to
: free internal memory, but still being able to use those apps if you want!
l*1
7 楼
楼主下一次 转载
注明出处啊
//www.blogger.com/profile/03513633746083109180
//tsukuba-yanagisawa.blogspot.com/
SUMMARY of alleged image manipulation
Article No.1 → J Biol Chem. 2010 May 7;285(19):14747-55.
Article No.2 → Cell. 2008 May 16;133(4):627-39.
Article No.3 → Mol Cell Biol. 2006 Nov;26(21):7966-76.
Article No.4 → EMBO J. 2006 Mar 8;25(5):1081-92.
Article No.5 → EMBO J. 2004 Dec 8;23(24):4813-23.
Article No.6 → EMBO J. 2004 Apr 7;23(7):1598-608.
Cell 2008:
//tsukuba-yanagisawa.blogspot.com/2012/02/epigenetic-control-of-rdna-loci-in
.html
Dental
article
Sacks
while
【在 F*Q 的大作中提到】
: Japanese Researcher Retracts 3 Articles in AHA Journals
: Akio Kawakami, a well published lipid researcher at Tokyo Medical and Dental
: University, has retracted 3 papers from AHA journals, including one article
: in AHA’s flagship journal Circulation. News of the retractions was first
: reported on Retraction Watch.
: Two of Kawakami’s co-authors are well known researchers affiliated with
: Harvard University and the Brigham and Women’s Hospital, Peter Libby and
: Frank Sacks. Prior to his position in Tokyo, Kawakami had been at the
: Harvard School of Public Health in the Department of Nutrition, where Sacks
: also works. Sacks is a co-author on all three of the retracted papers, while
注明出处啊
//www.blogger.com/profile/03513633746083109180
//tsukuba-yanagisawa.blogspot.com/
SUMMARY of alleged image manipulation
Article No.1 → J Biol Chem. 2010 May 7;285(19):14747-55.
Article No.2 → Cell. 2008 May 16;133(4):627-39.
Article No.3 → Mol Cell Biol. 2006 Nov;26(21):7966-76.
Article No.4 → EMBO J. 2006 Mar 8;25(5):1081-92.
Article No.5 → EMBO J. 2004 Dec 8;23(24):4813-23.
Article No.6 → EMBO J. 2004 Apr 7;23(7):1598-608.
Cell 2008:
//tsukuba-yanagisawa.blogspot.com/2012/02/epigenetic-control-of-rdna-loci-in
.html
Dental
article
Sacks
while
【在 F*Q 的大作中提到】
: Japanese Researcher Retracts 3 Articles in AHA Journals
: Akio Kawakami, a well published lipid researcher at Tokyo Medical and Dental
: University, has retracted 3 papers from AHA journals, including one article
: in AHA’s flagship journal Circulation. News of the retractions was first
: reported on Retraction Watch.
: Two of Kawakami’s co-authors are well known researchers affiliated with
: Harvard University and the Brigham and Women’s Hospital, Peter Libby and
: Frank Sacks. Prior to his position in Tokyo, Kawakami had been at the
: Harvard School of Public Health in the Department of Nutrition, where Sacks
: also works. Sacks is a co-author on all three of the retracted papers, while
M*o
8 楼
那你为啥从澳洲跑到英帝了？澳洲工资不是高多了嘛
【在 D******1 的大作中提到】
: 去的挺多的 我在澳洲的时候 面试10个里有5-6个都是美国来的。很多人都take了。当
: 然那是3年多以前了 不知道现在的情况
【在 D******1 的大作中提到】
: 去的挺多的 我在澳洲的时候 面试10个里有5-6个都是美国来的。很多人都take了。当
: 然那是3年多以前了 不知道现在的情况
b*n
9 楼
愿赌服输，一人做事一人当，比死不认错的老美老印强多了。
s*y
10 楼
因为没有那么多位置open啊。我倒是很想去，人家连面试都不给我的说。
如果有机会去，我倒是相当的怂恿你take the offer.
【在 d********g 的大作中提到】
: 研究氛围，待遇？如果有机会去，都需要考虑啥？
如果有机会去，我倒是相当的怂恿你take the offer.
【在 d********g 的大作中提到】
: 研究氛围，待遇？如果有机会去，都需要考虑啥？
V*1
11 楼
去非洲的更少，同理。
d*g
12 楼
为啥呢？我现在正在犹豫是否take this offer，
那美帝的绿卡怎么办？也不太好maintain吧？
【在 s******y 的大作中提到】
: 因为没有那么多位置open啊。我倒是很想去，人家连面试都不给我的说。
: 如果有机会去，我倒是相当的怂恿你take the offer.
那美帝的绿卡怎么办？也不太好maintain吧？
【在 s******y 的大作中提到】
: 因为没有那么多位置open啊。我倒是很想去，人家连面试都不给我的说。
: 如果有机会去，我倒是相当的怂恿你take the offer.
s*y
13 楼
都去澳洲了就别挂念着美国的绿卡了。
至于说为啥去，我是听说那里的压力小，生活也悠闲。
【在 d********g 的大作中提到】
: 为啥呢？我现在正在犹豫是否take this offer，
: 那美帝的绿卡怎么办？也不太好maintain吧？
至于说为啥去，我是听说那里的压力小，生活也悠闲。
【在 d********g 的大作中提到】
: 为啥呢？我现在正在犹豫是否take this offer，
: 那美帝的绿卡怎么办？也不太好maintain吧？
d*g
14 楼
现在听说也开始不那么容易了，不过应该还是比美帝好混吧总体上，不过工资待遇貌似
没啥优势啊，postdoc待遇确实比较高，但是AP其实比美国也差不多。。。
绿卡如果想维持，有什么办法么？什么白皮书好搞么？
没啥优势啊，postdoc待遇确实比较高，但是AP其实比美国也差不多。。。
绿卡如果想维持，有什么办法么？什么白皮书好搞么？
D*1
15 楼
工资是一回事，工作是另外一回事了。。
而且没准未来还会回澳洲，老婆一直想回去。不过最近小孩刚出生，近几年换地方不可
能了
【在 M****o 的大作中提到】
: 那你为啥从澳洲跑到英帝了？澳洲工资不是高多了嘛
d*g
16 楼
请教各位大牛，为啥澳洲的AP会被称为senior research fellow？听起来总像千老啊
【在 D******1 的大作中提到】
:
: 工资是一回事，工作是另外一回事了。。
: 而且没准未来还会回澳洲，老婆一直想回去。不过最近小孩刚出生，近几年换地方不可
: 能了
【在 D******1 的大作中提到】
:
: 工资是一回事，工作是另外一回事了。。
: 而且没准未来还会回澳洲，老婆一直想回去。不过最近小孩刚出生，近几年换地方不可
: 能了
M*o
17 楼
senior research fellow就是千老吧
【在 d********g 的大作中提到】
: 请教各位大牛，为啥澳洲的AP会被称为senior research fellow？听起来总像千老啊
【在 d********g 的大作中提到】
: 请教各位大牛，为啥澳洲的AP会被称为senior research fellow？听起来总像千老啊
d*g
18 楼
貌似他们那里新去的都是这样叫。。。但是给你startup，run lab，这都是faculty的
待遇啊
【在 M****o 的大作中提到】
: senior research fellow就是千老吧
待遇啊
【在 M****o 的大作中提到】
: senior research fellow就是千老吧
M*o
19 楼
那是research only position
有teaching的track是 lecturer->senior->associate->prof
【在 d********g 的大作中提到】
: 貌似他们那里新去的都是这样叫。。。但是给你startup，run lab，这都是faculty的
: 待遇啊
有teaching的track是 lecturer->senior->associate->prof
【在 d********g 的大作中提到】
: 貌似他们那里新去的都是这样叫。。。但是给你startup，run lab，这都是faculty的
: 待遇啊
D*1
20 楼
那你要当心了。澳洲AP就是AP,绝对不是research fellow. 虽然工资都是grade B.
参照这个帖子里我的回复，和英国的情况是一样的。
http://www.mitbbs.com/article_t/Faculty/31636963.html
【在 d********g 的大作中提到】
: 请教各位大牛，为啥澳洲的AP会被称为senior research fellow？听起来总像千老啊
x*t
21 楼
但是他们一般也只是给research only的职位好像
【在 s******y 的大作中提到】
: 因为没有那么多位置open啊。我倒是很想去，人家连面试都不给我的说。
: 如果有机会去，我倒是相当的怂恿你take the offer.
【在 s******y 的大作中提到】
: 因为没有那么多位置open啊。我倒是很想去，人家连面试都不给我的说。
: 如果有机会去，我倒是相当的怂恿你take the offer.
相关阅读
google开除那个是学生物的请教1 Ligation reaction question生信这个方向怎么样？ZT 主动撤稿：投案自首VS立功表现黑煤窑要塌了-川普改革 即将抛弃工资不达标的千老韩春雨撤稿，同行科学家如何评论？谈谈生物学科研工作者合理修饰数据的技巧test新人妹子求review机会自己的本职工作都做不好，总想着转行转 “韩春雨撤回论文”那家报道最狠？现在河北科技大学校长的内心怎么看韩春雨？吃着掺了老鼠屎的“八宝饭”，他们却成为中国的脊梁光明日报：将韩春雨推上神坛的诸多“推手”，需反思 (转载)有人能帮助解释下什么是 homoplastic snp 吗？转贴 从韩春雨的撤稿申明中我看到他很坏别谈韩春雨了，想想自己吧韩春雨团队同意按学校安排选择一家第三方实验室，在同行专家支持下开展实验，验证NgAgo-gDNA基因编辑的有效性，并将实验结果公布，以回应社会关切。有审稿机会吗？生物医学，癌症，生化，表观遗传学【记录历史】NgAgo’2016 第三阶段 Milestones